Tag: Prescription Drugs
AHA: Black Patients Less Likely to Receive Indicated BP Treatment Intensification
This accounts for about a quarter of the total effect on blood pressure control
Antipsychotic Use Declined in Young Children From 2009 to 2017
While there was a shift toward evidence-based indications, majority of use remains off-label
ACR: Incidence of COVID-19 Low in Patients With Rheumatic Disease
73 percent of those with SARS-CoV-2 infection not hospitalized; 11 percent of those hospitalized required ICU admission
AHA: Mavacamten May Treat Hypertrophic Cardiomyopathy
Improvements in cardiac structure, function seen at 30 weeks of treatment with mavacamten versus placebo
NHLBI Trial Concludes No Benefit for Hydroxychloroquine in COVID-19
No clinical benefit found for hydroxychloroquine versus placebo in hospitalized adults with COVID-19
Antibody Treatment Approved for Emergency Use Against Early COVID-19
Treatment approved for people newly infected with COVID-19 who are at high risk for progressing to severe disease
New Cancer Drug Approvals Linked to Drop in Mortality
New cancer drugs approved between 2000 and 2016 associated with 1,291,769 fewer related deaths in the U.S.
Cabotegravir Injection Can Protect Women From HIV for Two Months
Experimental drug found to be 89 percent more effective at preventing HIV infection than Truvada pills
Panel Recommends Against Approval of Experimental Drug for Alzheimer Disease
FDA panel concluded there is not enough evidence to support the clinical effectiveness of aducanumab
Drug Combo Offers Long-Term Glycemic Control in T2DM
Reduction in HbA1c at 104 weeks greater with exenatide plus dapagliflozin versus either drug alone
